Legend Capital
Mr. Li joined Legend Capital in 2001 as Vice President and was later promoted to Senior Vice President, Executive Director, and Managing Director. He is now Chief Investment Officer of the firm.
Mr. Li is responsible for LC’s investments in Amarsoft (300380.SZ), YIXINTANG (002727.SZ), La Chapelle (06116.HK), Anjie (002635.SZ), Pharmaron (300759.SZ), Lihua Group (300761.SZ), Wuxi Lead Auto Equipment (300450.SZ), Careray, Hichain, ASP, Dihon Pharmaceutical, 7gege, etc.
Mr. Li joined Legend Group in 1998, and prior to Legend Capital, he was the New Business Development Manager at the Group’s Business Development Dept.
Mr. Li holds a B.S. in Mechanical Engineering, a B.S. in Economics & Management and a master’s degree in Management Engineering from Tsinghua University, and an MBA from College Des Ingenieurs (Ecole Nationale des Ponts et Chaussées).
This person is not in any offices
Legend Capital
1 followers
In April 2001, Legend Capital was formed, and set up its first fund with US$35 mn commitment from Legend Holdings. Now Legend Capital is the independent Venture Capital investment subsidiary under the holdings company. In February 2012, Legend Capital took the new Chinese name "君联(Junlian)".